Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

Nafamostat, a serine proteinase inhibitor with various actions including antithrombin, antiplasmin, and antitrypsin effects, has been used in clinical practice to treat disseminated intravascular coagulation (DIC) and pancreatitis. This case report describes the clinical course of a patient with COV...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Infect Dis
Autors principals: Takahashi, Wakana, Yoneda, Taro, Koba, Hayato, Ueda, Tsukasa, Tsuji, Noriaki, Ogawa, Haruhiko, Asakura, Hidesaku
Format: Artigo
Idioma:Inglês
Publicat: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607231/
https://ncbi.nlm.nih.gov/pubmed/33157292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.10.093
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars